Heather L. McArthur, MD, MPH, of Cedars Sinai Medical Center, discusses advances in the treatment landscape for patients with triple-negative breast cancer. 

Babara L. Andersen, PhD, of Ohio State University, and Marlena M. Ryba, PhD, of Coastal Carolina University, discuss recognizing, assessing, referring, and monitoring patients with cancer experiencing moderate to severe anxiety or depression symptoms. 

In part two of this two-part podcast, William D. Tap, MD, of Memorial Sloan Kettering Cancer Center, continues his discussion of new advances in treating patients with sarcoma. 

In part one of this two-part podcast, William D. Tap, MD, of Memorial Sloan Kettering Cancer Center, discusses new advances in treating patients with sarcoma. 

Ramesh K. Ramanathan, MD, of the Mayo Clinic Cancer Center, Phoenix Campus, discusses new advances in treating patients with pancreatic cancer.

Adam P. Dicker, MD, PhD, of the Thomas Jefferson University Sidney Kimmel Cancer Center, walks us through the debate about the value of local treatment for newly diagnosed metastatic prostate cancer. 

Seth M. Pollack, MD, of the Fred Hutchinson Cancer Research Center, discusses immunotherapy for sarcoma and how varying microenvironments in sarcoma subtypes impact response to immunotherapy.

Nataliya V. Uboha, MD, PhD, of the University of Wisconsin’s Carbone Cancer Center, discusses the immunotherapy agents on the rise for treating esophageal cancers.